The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Hi Tornadotony,
What are your thoughts on this little analysis?
10:52 min into the video. https://m.youtube.com/watch?v=v-9BXdyH1VI
Thanks.
https://www.racap.com/media/Covid-19/COVID-19_TX_02122021_F.pdf?v=CNFIcLoxOVelx8rmM80x5Bp73mmxxain4lQd5EcZhyM
This therapeutics map will help put things in perspective, as well as showing the main players.
Synairgen is on course for FDA submission/approval in the coming weeks.
Connecting the dots is of great importance when we as investors, are limited in accessing privileged information.
Here’s what the UK Gov did with various partners (incl. Amazon & Thermo Fisher) to distribute testing kits a few months ago.
https://www.gov.uk/government/news/government-launches-new-drive-on-coronavirus-tests-for-frontline-nhs-staff
RM's statement:
"The trial is both a test of the drug, and a test of how technology can be utilised to deliver and manage the administration of an inhaled broad-spectrum antiviral to vulnerable patients in the context of a pandemic"
Hasn't SNG positioned itself as bio company with a drug/protein that is safe and works but also as a tech company that will disrupt traditional ways of providing care and treatment? Surely this new treatment model helps gov protect their citizens but also their medical assets.
Also, it is safe to assume that SNG is confident on the safety and efficacy of SNG001. Could one (using pmjh's forensic insight) be led to believe that the home trials will be used to help draft the new rule book on distance care giving, as well as fine tuning the nebuliser before manufacturers start increasing production. Am I wrong to believe that they are a couple of patents in the pipelines?
Finally, in terms of logistics and couriers, would it be far fetched to imagine SNG already talking to Amazon (or vice versa) as a possible partner to deliver the product (nebuliser & drug) to patients? I believe a similar deal was reached between the UK Gov and Amazon when it wanted to ramp up testing kits delivery.
It seems to me that everything has been designed to line up and be perfectly synced, ahead of the final announcement which will deliver a new drug, a new product, and a new methodology. I think the USA market will be the spark that ignites the SNG fireworks. not long to go.
Thanks yet again to pmjh's research and calm outlook. Dafad is up there too, with that amazing Kensas University youtube interview.
Another day, another great find Dafad.
Thank you for sharing your research.
Dr Leslie Spikes is fabulous. She gives the "inhaled and oral therapies" the thumbs up, qualifying them of game changer therapies.
Hats off Tornadotony!
Just read again your original post dated 15th Dec. Bravo!
"My Synairgen Chart Assessment 15 Dec 2020 21:38
The following is my personal opinion on how I see the current chart pattern. It is apparent that since 8th December a support line has built up on the 4 hourly chart. The close tonight is just above the new support line which has been sustained without any major breaches. The resistance lines above are at 98p and 102p. The chart is forming a triangle with the December 8th spike to 100-102p. If Synairgen continues on its same path the triangle will complete either Friday or the following Monday morning at the open. Completion of the move may coincide with a news event by the company or some other source. The pattern appears bullish in my opinion. Once 102p is breached a possible breakout rise may occur and of course gets sold into at some point to be taken back to the support line.
Examination of the 3 monthly chart also shows an inverse head and shoulders formation with the neckline on the right shoulder forming around 100p-105p. This pattern is also bullish.
Support lines are at 82p and 88p.
I do appreciate that chart patterns have limits on their reliability. However I thought I would comment on what I see.
Regards Tony"
Merci try2buylow.
Aurélien Mary is not stating that SNG001 will be sold in France on 15th Oct. He's saying that the french regulators will be granting an authorisation (known as an ATU or Authorisation Temporaire d'Utilisation) for its therapeutic use in specific circumstances. An encouraging development!
more here: https://www.ansm.sante.fr/Activites/Autorisations-temporaires-d-utilisation-ATU/Qu-est-ce-qu-une-autorisation-temporaire-d-utilisation/(offset)/1
Great find pmjh. Thank you.
Aurélien Mary
https://clinicaltrials.gov/ct2/show/NCT04469491
https://racetoacure.stanford.edu/clinical-trials/1401
https://france3-regions.francetvinfo.fr/hauts-de-france/somme/amiens/coronavirus-interferon-inhale-nouveau-traitement-prone-pharmacien-du-chu-amiens-essai-clinique-1817382.html